Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 6, 2023 | Connecta Therapeutics, participada por Inveready, iniciado los ensayos clínicos de su fármaco para el tratamiento del síndrome X frágil | 06/06/2023 Nota de prensa CONNECTA THERAPEUTICS, PARTICIPADA POR INVEREADY, INICIADO LOS ENSAYOS CLÍNICOS DE SU FÁRMACO PARA EL TRATAMIENTO DEL SÍNDROME X FRÁGIL Connecta Therapeutics, compañía biotecnológica en fase clínica especializad... |
| Jun 28, 2018 | 12 Stunning Tech, Research & Innovation Hubs In Barcelona | Not only does Barcelona host leading European universities such EADA, ESADE and IESE, but it’s also becoming one of the biggest tech hubs in Europe – bringing together successful researchers, innovators and entrepreneurs from all over the w... |
Reviews 0
FAQ about IMIM
What has the press written about IMIM?
Parsers VC has collected 3 articles mentioning IMIM, among them “Connecta Therapeutics, participada por Inveready, iniciado los ensayos clínicos de su fármaco para el tratamiento del síndrome X frágil” (Jun 6, 2023) and “12 Stunning Tech, Research & Innovation Hubs In Barcelona” (Jun 28, 2018).
Is IMIM still active?
Yes, IMIM is active; its latest activity on Parsers VC dates from Jul 26, 2024.